ANSGAR SANTEL

Person

BERLIN, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Lipids, lipid complexes and use thereof
- Patent number 9,486,538
- Issue date Nov 8, 2016
- Silence Therapeutics GmbH
- Oliver Keil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Means for inhibiting the expression of ANG2
- Patent number 9,458,461
- Issue date Oct 4, 2016
- Silence Therapeutics GmbH
- Ansgar Santel
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Lipids, lipid complexes and use thereof
- Patent number 9,125,820
- Issue date Sep 8, 2015
- Silence Therapeutics GmbH
- Oliver Keil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Means for inhibiting the expression of ANG2
- Patent number 8,829,179
- Issue date Sep 9, 2014
- Silence Therapeutics GmbH
- Ansgar Santel
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Lipids, lipid complexes and use thereof
- Patent number 8,735,453
- Issue date May 27, 2014
- Silence Therapeutics GmbH
- Oliver Keil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Means for inhibiting the expression of Orc-1
- Patent number 8,722,875
- Issue date May 13, 2014
- Silence Therapeutics GmbH
- Manfred Gossen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Lipids, lipid complexes and use thereof
- Patent number 8,357,722
- Issue date Jan 22, 2013
- Silence Therpeutics AG
- Oliver Keil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Means for inhibiting the expression of protein kinase 3
- Patent number 8,232,256
- Issue date Jul 31, 2012
- Silence Therapeutics AG
- Jorg Kaufmann
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Mitofusins, Fzo Homologs and functional derivatives thereof
- Patent number 6,953,680
- Issue date Oct 11, 2005
- The Board of Trustees of the Leland Stanford, Junior University
- Margaret T. Fuller
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
LIPOPLEX FORMULATIONS FOR SPECIFIC DELIVERY TO VASCULAR ENDOTHELIUM
- Publication number 20170296469
- Publication date Oct 19, 2017
- Silence Therapeutics GMBH
- JORG KAUFMANN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LIPIDS, LIPID COMPLEXES AND USE THEREOF
- Publication number 20170036990
- Publication date Feb 9, 2017
- Silence Therapeutics GMBH
- OLIVER KEIL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
LIPIDS, LIPID COMPLEXES AND USE THEREOF
- Publication number 20150359906
- Publication date Dec 17, 2015
- Silence Therapeutics GMBH
- OLIVER KEIL
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
LIPIDS, LIPID COMPLEXES AND USE THEREOF
- Publication number 20140329885
- Publication date Nov 6, 2014
- OLIVER KEIL
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MEANS FOR INHIBITING THE EXPRESSION OF ANG2
- Publication number 20140328903
- Publication date Nov 6, 2014
- SILENCE THERAPEUTICS AG
- Ansgar Santel
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MEANS FOR INHIBITING THE EXPRESSION OF ORC-1
- Publication number 20140249207
- Publication date Sep 4, 2014
- Silence Therapeutics GMBH
- MANFRED GOSSEN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
LIPIDS, LIPID COMPLEXES AND USE THEREOF
- Publication number 20130165381
- Publication date Jun 27, 2013
- SILENCE THERAPEUTICS AG
- OLIVER KEIL
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
LIPIDS, LIPID COMPLEXES AND USE THEREOF
- Publication number 20120065138
- Publication date Mar 15, 2012
- SILENCE THERAPEUTICS AG
- OLIVER KEIL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MEANS FOR INHIBITING THE EXPRESSION OF ANG2
- Publication number 20120022138
- Publication date Jan 26, 2012
- SILENCE THERAPEUTICS AG
- Ansgar Santel
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
LIPIDS, LIPID COMPLEXES AND USE THEREOF
- Publication number 20110294871
- Publication date Dec 1, 2011
- SILENCE THERAPEUTICS AG
- OLIVER KEIL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MEANS FOR INHIBITING THE EXPRESSION OF ORC-1
- Publication number 20110217367
- Publication date Sep 8, 2011
- SILENCE THERAPEUTICS AG
- Manfred Gossen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Means for Inhibiting the Expression of Protein Kinase 3
- Publication number 20090304678
- Publication date Dec 10, 2009
- Jorg Kaufmann
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MEANS FOR INHIBITING THE EXPRESSION OF CD31
- Publication number 20090252783
- Publication date Oct 8, 2009
- SILENCE THERAPEUTICS AG
- Jorg Kaufmann
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
LIPOPLEX FORMULATIONS FOR SPECIFIC DELIVERY TO VASCULAR ENDOTHELIUM
- Publication number 20090074852
- Publication date Mar 19, 2009
- SILENCE THERAPEUTICS AG
- Jorg Kaufmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Mitofusins, Fzo homologs and functional derivatives thereof
- Publication number 20020168673
- Publication date Nov 14, 2002
- Margaret T. Fuller
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

ANSGAR SANTEL

Person

Patents Grantslast 30 patents

Lipids, lipid complexes and use thereof

Means for inhibiting the expression of ANG2

Lipids, lipid complexes and use thereof

Means for inhibiting the expression of ANG2

Lipids, lipid complexes and use thereof

Means for inhibiting the expression of Orc-1

Lipids, lipid complexes and use thereof

Means for inhibiting the expression of protein kinase 3

Mitofusins, Fzo Homologs and functional derivatives thereof

Patents Applicationslast 30 patents

LIPOPLEX FORMULATIONS FOR SPECIFIC DELIVERY TO VASCULAR ENDOTHELIUM

LIPIDS, LIPID COMPLEXES AND USE THEREOF

LIPIDS, LIPID COMPLEXES AND USE THEREOF

LIPIDS, LIPID COMPLEXES AND USE THEREOF

MEANS FOR INHIBITING THE EXPRESSION OF ANG2

MEANS FOR INHIBITING THE EXPRESSION OF ORC-1

LIPIDS, LIPID COMPLEXES AND USE THEREOF

LIPIDS, LIPID COMPLEXES AND USE THEREOF

MEANS FOR INHIBITING THE EXPRESSION OF ANG2

LIPIDS, LIPID COMPLEXES AND USE THEREOF

MEANS FOR INHIBITING THE EXPRESSION OF ORC-1

Means for Inhibiting the Expression of Protein Kinase 3

MEANS FOR INHIBITING THE EXPRESSION OF CD31

LIPOPLEX FORMULATIONS FOR SPECIFIC DELIVERY TO VASCULAR ENDOTHELIUM

Mitofusins, Fzo homologs and functional derivatives thereof